Log In
Print this Print this

Oral azacitidine (CC-486)

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionOral formulation of the hypomethylating agent azacitidine
Molecular Target DNA methyltransferase
Mechanism of ActionDNA methyltransferase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today